Citation Impact
Citing Papers
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors
2021
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
2010 StandoutNobel
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Epidemiology of Malignant Melanoma, Worldwide Incidence, and Etiologic Factors
1993
Expansive discovery of chemically diverse structured macrocyclic oligoamides
2024 StandoutScienceNobel
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus
2006
Basal-Cell Carcinoma
2005
Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer?
1995
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
2001 Standout
Mutations induced by ultraviolet light
2005
Focus on melanoma
2002
The Prognostic Importance of Tumor Mitotic Rate Confirmed in 1317 Patients With Primary Cutaneous Melanoma and Long Follow-Up
2004
Efficacy of Lymphatic Mapping, Sentinel Lymphadenectomy, and Selective Complete Lymph Node Dissection as a Therapeutic Procedure for Early-Stage Melanoma
1999
Generation of Human Melanocytes from Induced Pluripotent Stem Cells
2011 StandoutNobel
UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer
2011
Toxic effects of ultraviolet radiation on the skin
2003
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Biomarkers in melanoma: predisposition, screening and diagnosis
2003
Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis
1997
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
2007
Epidemiology of melanoma
2000
Keratoacanthoma
1994
BRAFE600-associated senescence-like cell cycle arrest of human naevi
2005 StandoutNature
Dermatologist-level classification of skin cancer with deep neural networks
2017 StandoutNature
Squamous cell carcinoma of skin with perineural invasion
1994
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Prognostic significance of autoimmunity during treatment of melanoma with interferon
2011
Sentinel-Node Biopsy or Nodal Observation in Melanoma
2006 Standout
Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7—challenging the concept of dysplastic nevi as precursor lesions?
2010
Sunlight exposure and pathogenesis of uveal melanoma
2004
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer
2003
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis
1998
Melanocyte biology and skin pigmentation
2007 Nature
CLASSIFICATION AND STAGING OF MELANOMA
1998
Polymer conjugates as anticancer nanomedicines
2006 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Is there more than one road to melanoma?
2004
Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)
2000
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
1989 Standout
Distinct Sets of Genetic Alterations in Melanoma
2005 Standout
Metastases from squamous cell carcinoma of the skin and lip
1989
Sunlight: A major factor associated with the development of melanocytic nevi in Australian schoolchildren
1994
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
2009 Standout
Proliferative activity of primary cutaneous melanocytic tumours
1993
Emerging concepts and technologies in melanoma research
2002
Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis
1995 Standout
Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi
2004
Thin Malignant Melanomas and Recurrence Potential
1987
Hereditary Colorectal Cancer
2003 Standout
Age as a prognostic factor in the malignant melanoma population
1994
S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma
2004
Prognostic Factors in Thin Cutaneous Malignant Melanoma
1990
Cancer immunotherapy comes of age
2011 StandoutNature
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Aggressive basal cell carcinoma: Presentation, pathogenesis, and management
2004
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
1996 Standout
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Squamous cell carcinoma of the skin (excluding lip and oral mucosa)
1992
Identification by cDNA Microarray Technology of Genes Modulated by Artificial Ultraviolet Radiation in Normal Human Melanocytes: Relation to Melanocarcinogenesis
2001
Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysis
1993
Epidemiologic Evidence for Different Roles of Ultraviolet A and B Radiation in Melanoma Mortality Rates
2003
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease
1988
Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations
2008 Standout
Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?
1999
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Nonmelanoma Cancers of the Skin
1992
Mutations in GNA11 in Uveal Melanoma
2010 Standout
The prognosis of patients with stage III melanoma prospective long-term study of 286 patients of the fachklinik hornheide
1993
Cutaneous Squamous-Cell Carcinoma
2001 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Prognostic factors in thin cutaneous malignant melanoma
1994
Invasive Cutaneous Melanoma in Elderly Patients
1991
The Lives of Pigment Cells
1989
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
Cowden's disease (multiple hamartoma and neoplasia syndrome)
1983 Standout
The Choice of Animal Tumors for Experimental Studies of Cancer Therapy
1978
Atomic Layer Deposition: An Overview
2009 Standout
Atomic Layer Deposition of UV‐Absorbing ZnO Films on SiO2 and TiO2 Nanoparticles Using a Fluidized Bed Reactor
2008
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Nanoparticles in Photodynamic Therapy
2015 Standout
Synthetic biologically active polymers
1975
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Four faces of cellular senescence
2011 Standout
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Wound Healing: A Cellular Perspective
2018 Standout
The pathogenesis of cancer metastasis
1980 StandoutNature
Enabling quantification of protein concentration in human serum biopsies using attenuated total reflectance – Fourier transform infrared (ATR-FTIR) spectroscopy
2018
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
Thin Malignant Melanomas With Regression and Metastases
1987
Human skin pigmentation: melanocytes modulate skin color in response to stress
2007 Standout
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
2001
Works of Robert S. Bart being referenced
Recurrence Rates of Treated Basal Cell Carcinomas: Part 1: Overview
1991
Recurrence Rates of Treated Basal Cell Carcinomas: Part 2: Curettage‐Electrodesiccation
1991
Laboratory tests and imaging studies in patients with cutaneous malignant melanoma
1998
Recurrence Rates of Treated Basal Cell Carcinomas
1992
Risk of melanoma in medium-sized congenital melanocytic nevi: A follow-up study
1998
Ultraviolet A and melanoma: A review
2001
Reduction of ultraviolet transmission through cotton t-shirt fabrics with low ultraviolet protection by various laundering methods and dyeing: Clinical implications
2001
Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: A survey of experienced physicians
1997
Management of cutaneous malignant melanoma by dermatologists of the American Academy of Dermatology. I. Survey of biopsy practices of pigmented lesions suspected as melanoma
1995
Influence of gender on survival in patients with stage I malignant melanoma
1992
Age and malignant melanoma: Comparison of variables in different age-groups
1989
Atypical mole syndrome: Risk factor for cutaneous malignant melanoma and implications for management
1995
A study of large congenital melanocytic nevi and associated malignant melanomas: Review of cases in the New York University registry and the world literature
1997
Techniques of cutaneous examination for the detection of skin cancer
1995
Risk Factors for the Development of Malignant Melanoma—I: Review of Case‐Control Studies
1988
Large Congenital Melanocytic Nevi and the Risk for Development of Malignant Melanoma and Neurocutaneous Melanocytosis
2000
Tumor Conference #8: Squamous‐Cell Carcinoma of the Ear With Regional Metastases
1976
Prevalence of Nevocytic Nevi on Lateral and Medial Aspects of Arms
1978
Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
1997
Predicting ten-year survival of patients with primary cutaneous melanoma
1997
Tumor Conference #23: Development of More Keratoacanthomas Following Skin Testing with Nitrogen Mustard in a Patient with the Multiple Keratoacanthoma Syndrome
1979
Malignant Melanoma: A Review
1977
Breslow thickness and Clark level in melanoma
2000
Prognostic index for malignant melanoma
1987
Inhibition of growth of B16 murine malignant melanoma by exogenous interferon.
1980
Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
2000
Late recurrence of malignant melanoma
1991
Prospective Follow‐Up for Malignant Melanoma in Patients with Atypical‐Mole (Dysplastic‐Nevus) Syndrome
1991
Tumor Conference #35
1981
Role of Interferon in the Anti-Melanoma Effects of Poly (I).Poly (C) and Newcastle Disease Virus
1973
Correlation of Thicknesses of Superficial Spreading Malignant Melanomas and Ages of Patients
1981
Hazard-rate analysis in state I malignant melanoma.
1986
Metastases of thin melanomas
1983
Growth and Immunogenicity of Murine B-16 Melanoma*
1974
Inhibition of the Growth of Murine Malignant Melanoma with Synthetic Double-stranded Ribonucleic Acid
1969 Nature